Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Blood|August 31, 2019
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockadeDaniel A Rauch, Kevin C Conlon, Murali Janakiram, et al.
The Journal of Experimental Medicine|September 14, 2011
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemiaChristian Hurtz, Katerina Hatzi, Leandro Cerchietti, et al.
Nature Immunology|May 27, 2014
The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cellsHaikun Wang, Jianlin Geng, Xiaomin Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2019
The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma AgentsFilippo Spriano, Elaine Yee Lin Chung, Eugenio Gaudio, et al.
The Journal of Experimental Medicine|May 26, 2010
BCL6 is critical for the development of a diverse primary B cell repertoireCihangir Duy, J Jessica Yu, Rahul Nahar, et al.
Nature|May 20, 2011
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
JCO Precision Oncology|July 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected CasesNishi Shah, Melissa Suchanek, Astha Thakkar, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOPXin Huang, Bin Meng, Javeed Iqbal, et al.
Blood|August 15, 2018
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapiesUrvi A Shah, Elaine Y Chung, Orsi Giricz, et al.
Pageof 8